The genetic testing leader continues to set new quarterly revenue records.
News & Analysis: NeoGenomics, Inc.
NEO earnings call for the period ending March 31, 2019.
Quarterly earnings from around the industry suggested the epic growth opportunity isn't slowing down anytime soon.
NEO earnings call for the period ending December 31, 2018.
The group rebounded after a terrible end to 2018, but each has big plans for the year ahead.
Start the year off the right way by injecting some long-term growth potential into your portfolio with one (or all) of these stocks.
It was nothing the medical diagnostics company did.
Shares are getting slammed after management issued disappointing guidance.
NeoGenomics gets a lift from a price target hike, but you'll want to keep your eyes on the bigger picture.
News of a potentially transformative acquisition got investors excited, pushing shares higher.